logo
episode-header-image
Aug 2024
54m 45s

How 23andMe went from a $6 billion valua...

Fast Company
About this episode
Cofounder and CEO of 23andMe, Anne Wojcicki, wants to take the public company private. Founded in 2006, the DNA-testing startup was valued at $6 billion in 2021. Now, it’s trading for less than a dollar. So what happened? ‘Fast Company’ senior writer Ainsley Harris breaks down 23andMe’s history, and why the company faces an uncertain future. Also, actor Edwa ... Show More
Up next
Jan 2025
Teflon Son? How Softbank CEO Masayoshi Son’s legend keeps growing
On today’s episode, host Josh Christensen is joined by ‘Fast Company’ associate editor David Salazar to help break down the latest news in the world of business and innovation, including the fallout from DeepSeek’s LLM launch, the backtracked federal funding freeze, and the risin ... Show More
1 h
Jan 2025
Police departments are embracing AI-enhanced surveillance technology to stop crime
Police departments across the country are embracing AI-enhanced surveillance technology in the name of stopping crime. One prominent security firm called Flock Safety is leading the effort and profiting off our fears. Fast Company Senior Writer Ainsley Harris joined Yaz and Josh ... Show More
54m 4s
Dec 2024
Why the NFL, Universal Pictures, and erotic audio company Quinn made our Brands That Matter list
On today’s episode, Yaz and Josh are joined by ‘Fast Company’ senior staff editor Jeff Beer and ‘Fast Company’ associate editor David Salazar to discuss the annual Brands That Matter list. This year, the list includes not just such companies as Athletic Brewing, Quinn Erotic Audi ... Show More
1h 9m
Recommended Episodes
Jun 2025
23andMe's Fatal Flaw | Defying Gravity? | 2
Plagued by low sales of its genetic tests, 23andMe adopts a bold new plan: slash prices and enter the pharmaceutical industry. But with investors nervous, can CEO Anne Wojcicki keep the show going long enough to make her DNA dream pay off?Be the first to know about Wondery’s newe ... Show More
39m 17s
Jan 2022
20VC: 23andMe's Anne Wojcicki on How To Approach Trust in Business and Personal Relationships, Leadership Lessons from Sheryl Sandberg and Reflections on How The Best Founders Manage Their Boards
tail spinning
41m 13s
Jun 2025
23andMe's Fatal Flaw | Guess Who’s Back | 3
Just when it looked like 23andMe was selling to Regeneron Pharmaceuticals, founder Anne Wojcicki placed a bid through her new nonprofit in an attempt to win it back at the eleventh hour. Lila MacLellan, Senior Writer at Fortune, joins David to discuss Wojcicki’s leadership style, ... Show More
37m 55s
May 2021
CEO Series: 23andMe’s Anne Wojcicki on Scientific Breakthroughs and Public Trust
Anne Wojcicki, CEO of 23andMe, spent a decade in healthcare and biotechnology before launching the DNA testing and analysis company in 2006. Her goal was twofold: to help individuals learn more about their own genetics, enabling them to pursue more personalized medical care, and ... Show More
23m 55s
Aug 2021
372: Biotech Billionaire Anne Wojcicki, Cofounder and CEO of 23andMe
You’ve heard data has the power to make or break a business. Nobody knows this more than Anne Wojcicki, co-founder of biotech giant 23andMe. After 15 years of leveraging data to build a game-changing company, Wojcicki made headlines this summer when she became the latest self-mad ... Show More
53m 20s
Jun 2025
23andMe's Fatal Flaw | Great Expectorations | 1
When Silicon Valley power-player Anne Wojcicki sees gold in genetics, she forms 23andMe. She wants to bring genetic testing to the masses. But behind the hype and celebrity endorsements, can she build a company that’s selling more than just an expensive novelty product? Be the fi ... Show More
36m 42s
Apr 2024
Extra: Why Is 23andMe Going Under? (Update)
<p>Five years ago, we published an episode about the boom in home DNA testing kits, focusing on the high-flying firm 23andMe and its C.E.O. Anne Wojcicki. Their flight has been extremely bumpy since then. This update includes an additional interview with the <i>Wall Street Journa ... Show More
1h 2m
Mar 2025
The rise and fall of DNA testing company 23andMe
The genetic testing firm 23andMe has filed for bankruptcy, another twist in the story of a company that promised a pioneering approach to precision health. Now users are scrambling to delete their personal data, with the future ownership of the firm uncertain. To understand the h ... Show More
21m 49s
Apr 2025
DNA and Bankruptcy Collide With 23andMe
The genetic testing company 23andMe filed for bankruptcy in March, after years of slowing sales, legal trouble, and a declining stock price. And now, the valuable trove of genetic data the company owns is for sale, sparking privacy concerns.  On today’s Big Take, Bloomberg biotec ... Show More
16m 30s